U.K. Menopause Market Size & Outlook, 2025-2030
Global Market
Related Markets
UK menopause market highlights
- The UK menopause market generated a revenue of USD 490.1 million in 2024 and is expected to reach USD 648.1 million by 2030.
- The UK market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2024.
- Hormonal is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2024 | USD 490.1 million |
| Market revenue in 2030 | USD 648.1 million |
| Growth rate | 4.8% (CAGR from 2025 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Hormonal |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal, Non-Hormonal, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, UK accounted for 2.8% of the global menopause market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany menopause market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 453.0 million by 2030.
The NHS has identified the average age of menopause in women as 51 years in the UK, with exceptions that enter menopause before 40 years of age or even in their 30s. It estimated around 13 million women, or around one-third of the female population in the UK, being premenopausal or menopausal. Considering the large target population, researchers are innovating products to ease the transition of women through menopause.
Cambridge Diagnostic Imaging (CaDi), a provider of nutraceutical products for health support, announced the launch of Lycovary Daily in December 2020. The product is a food supplement developed by a biotech company, Lycotec, designed for ovarian health. It provides targeted anti-aging oxygenation, supporting women through the fertile phase and menopause transition.
No credit card required*
Publish Date: May 30, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22,822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | www.drreddys.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Nestle SA | View profile | 270,000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | www.nestle.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Theramex | View profile | 251-500 | London, England, United Kingdom, Europe | theramex.com/ |
| Rainbow Light Nutritional Systems | View profile | 51-100 | Santa Cruz, California, United States, North America | www.rainbowlight.com/ |
| Padagis | View profile | 251-500 | Allegan, Michigan, United States, North America | www.padagis.com |
U.K. Menopause Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Menopause Market Outlook will help companies and investors design strategic landscapes.
Dietary Supplements was the largest segment with a revenue share of 98.12% in 2024.
Horizon Databook has segmented the U.K. menopause market based on hormonal, non-hormonal, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The NHS has identified the average age of menopause in women as 51 years in the UK, with exceptions that enter menopause before 40 years of age or even in their 30s. It estimated around 13 million women, or around one-third of the female population in the UK, being premenopausal or menopausal. Considering the large target population, researchers are innovating products to ease the transition of women through menopause.
Cambridge Diagnostic Imaging (CaDi), a provider of nutraceutical products for health support, announced the launch of Lycovary Daily in December 2020. The product is a food supplement developed by a biotech company, Lycotec, designed for ovarian health. It provides targeted anti-aging oxygenation, supporting women through the fertile phase and menopause transition.
- U.K. Menopause Market treatment Outlook (Revenue, USD Million , 2018-2030)
- Hormonal
- Non-Hormonal
- Dietary Supplements
Reasons to subscribe to Menopause Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Menopause Market Outlook databook
- Our clientele includes a mix of Menopause Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Menopause Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Menopause Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.K. Menopause Market, 2018-2030 (US$M)
UK Treatment - Menopause Market Statistics, 2024 - 2030 (US$M)
